Option Care Health, Inc. (NASDAQ:OPCH)
| Market Cap | 4.64B+13.4% |
| Revenue (ttm) | 5.69B+5.9% |
| Net Income | 209.58M-0.8% |
| EPS | 1.33+6.4% |
| Shares Out | 149.79M |
| PE Ratio | 23.31 |
| Forward PE | 14.87 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 65,073,125 |
| Open | 31.04 |
| Previous Close | 23.37 |
| Day's Range | 30.96 - 31.11 |
| 52-Week Range | 18.01 - 36.80 |
| Beta | 0.61 |
| Analysts | Buy |
| Price Target | 28.88(-6.84%) |
| Earnings Date | Oct 29, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About OPCH
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$OPCH stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in OPCH holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by OPCH's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
OPCH Estimated quarterly lobbying spending
Source: U.S. Senate LDA
OPCH Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Commercial payers | $1.24B | 85.73% |
| Government payers | $186.43M | 12.93% |
| Patients | $19.40M | 1.34% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New OPCH patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to OPCH from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in OPCH
| ETF | Est. Holding Size |
|---|---|
| IJHiShares Core S&P Mid-Cap ETF | $125.49M |
| VTIVanguard Morningstar Total Stock Market ETF | $117.05M |
| IWMiShares Russell 2000 ETF | $97.17M |
| VBVanguard Morningstar Small-Cap ETF | $84.72M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $48.73M |
| DFATDimensional - US Targeted Value ETF | $47.75M |
Estimated from each fund’s disclosed top holdings × AUM
OPCH Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from OPCH’s recent data — informational, not investment advice